Using the maintrac system we detected EpCAM+ CTC in 97% of MCC patients with a median of 450 cells/ml, and EpCAM+ CD56+ CTC in 70% of MCC patients with a median of 150 cells/ml. The gene discussed is NCAM1; the disease is Merkel cell skin cancer.